Enantioselective and nonlinear intestinal absorption of eflornithine in the rat

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 8, 2008, Pages 2842-2848

  Jansson, R ^a   Malm, M ^b,c   Roth, C ^a   Ashton, M ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b DALARNA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; ENANTIOMER; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE ABSORPTION; INTESTINE TRANSIT TIME; ISOMER; LIGHT SCATTERING; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STEREOCHEMISTRY; STEREOSPECIFICITY; ULTRAVIOLET RADIATION;

ADMINISTRATION, ORAL; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EFLORNITHINE; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; MALE; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM; TRYPANOCIDAL AGENTS;

EID: 48749094973     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00050-08     Document Type: Article

References (21)

1. Anonymous. 2006. Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly. Epidemiol. Rec. 81:71-80.
2. Anonymous. August 2006. African trypanosomiasis (sleeping sickness). World Health Organization, Geneva, Switzerland.
3. Bacchi, C. J., H. C. Nathan, S. H. Hutner, P. P. McCann, and A. Sjoerdsma. 1980. Polyamine metabolism: a potential therapeutic target in trypanosomes. Science 210:332-334.
4. Balasegaram, M., S. Harris, F. Checchi, S. Ghorashian, C. Hamel, and U. Karunakara. 2006. Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo. Bull. W. H. O. 84:783-791.
5. Barrett, M. P. 2006. The rise and fall of sleeping sickness. Lancet 367:1377-1378.
6. Barrett, M. P., D. W. Boykin, R. Brun, and R. R. Tidwell. 2007. Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. Br. J. Pharmacol. 152:1155-1171.
7. Burri, C., and R. Brun. 2003. Eflornithine for the treatment of human African trypanosomiasis. Parasitol. Res. 90(Suppl. 1):S49-S52.
8. Burri, C., and J. Keiser. 2001. Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment. Trop. Med. Int. Health 6:412-420.
9. Chiou, W. L., and A. Barve. 1998. Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm. Res. 15:1792-1795.
10. Griffin, C. A., M. Slavik, S. C. Chien, J. Hermann, G. Thompson, O. Blanc, G. D. Luk, S. B. Baylin, and M. D. Abeloff. 1987. Phase I trial and pharmacokinetic study of intravenous and oral alpha-difluoromethylornithine. Investig. New Drugs 5:177-186.
11. Grove, J., J. R. Fozard, and P. S. Mamont. 1981. Assay of alpha-difluoromethylornithine in body fluids and tissues by automatic amino-acid analysis. J. Chromatogr. 223:409-416.
12. Haegele, K. D., R. G. Alken, J. Grove, P. J. Schechter, and J. Koch-Weser. 1981. Kinetics of alpha-difluoromethylornithine: an irreversible inhibitor of ornithine decarboxylase. Clin. Pharmacol. Ther. 30:210-217.
13. Kennedy, P. G. 2006. Human African trypanosomiasis: in and out of Africa. Neurology 66:962-963.
14. Kibona, S. N., L. Matemba, J. S. Kaboya, and G. W. Lubega. 2006. Drug-resistance of Trypanosoma b. rhodesiense isolates from Tanzania. Trop. Med. Int. Health 11:144-155.
15. Malm, M., and Y. Bergqvist. 2007. Determination of eflornithine enantiomers in plasma, by solid-phase extraction and liquid chromatography with evaporative light-scattering detection. J. Chromatogr. B 846:98-104.
16. Na-Bangchang, K., F. Doua, J. Konsil, W. Hanpitakpong, B. Kamanikom, and F. Kuzoe. 2004. The pharmacokinetics of eflornithine (alpha-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness. Eur. J. Clin. Pharmacol. 60:269-278.
17. Osterberg, O., R. M. Savic, M. O. Karlsson, U. S. Simonsson, J. P. Norgaard, J. V. Walle, and H. Agerso. 2006. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults. J. Clin. Pharmacol. 46:1204-1211.
18. Qu, N., N. A. Ignatenko, P. Yamauchi, D. E. Stringer, C. Levenson, P. Shannon, S. Perrin, and E. W. Gerner. 2003. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine. Biochem. J. 375:465-470.
19. Savic, R. M., D. M. Jonker, T. Kerbusch, and M. O. Karlsson. 2007. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J. Pharmacokinet. Pharmacodyn. 34:711-726.
20. Smithers, J. 1988. Aprecolumn derivatization high-performance liquid chromatographic (HPLC) procedure for the quantitation of difluoromethylornithine in plasma. Pharm. Res. 5:684-686.
21. Welburn, S. C., and M. Odiit. 2002. Recent developments in human African trypanosomiasis. Curr. Opin. Infect. Dis. 15:477-484.